SCHEMBL6955320

SCHEMBL6955320

CCOc1ccc2c[c][nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.53
ALDH1A1 P00352 3/20 0.53
HSD17B10 Q99714 3/20 0.49
MAPT P10636 2/20 0.49
ESR2 Q92731 1/20 0.49
PSMB8 P28062 1/20 0.45
NQO1 P15559 1/20 0.45
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 2/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533492 0.79 MEN1 (0.53) HPGDALDH1A1HSD17B10MAPTPSMB8
SCHEMBL29629327 0.76 NQO1 (0.68) HPGDALDH1A1HSD17B10MAPTESR2
SCHEMBL3825385 0.76 NQO1 (0.68) HPGDALDH1A1HSD17B10MAPTESR2
SCHEMBL5257014 0.74 DRD3 (0.54) HPGDALDH1A1KDM4EMEN1KMT2A
SCHEMBL9740911 0.74 TUBB1 (0.57) HPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL827340 0.73 MEN1 (0.65) HPGDALDH1A1HSD17B10MAPTESR2
SCHEMBL23458226 0.72 NQO1 (0.62) HPGDALDH1A1HSD17B10MAPTESR2
SCHEMBL29779700 0.72 NQO1 (0.62) HPGDALDH1A1HSD17B10MAPTESR2
SCHEMBL3821099 0.72 NQO1 (0.62) HPGDALDH1A1HSD17B10MAPTESR2
SCHEMBL6958413 0.72 CYP1A2 (0.45) ALDH1A1MAPTNPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US claimed
EP-0993458-B1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 2003-04-09 EP disclosed
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US disclosed
EP-0998474-A1 PIPERAZINE DERIVATIVES MERCK PATENT GmbH (DE) 2000-05-10 EP disclosed
EP-0993458-A1 3-BENZYLPIPERIDINE MERCK PATENT GmbH (DE) 2000-04-19 EP disclosed
WO-1999003855-A1 PIPERAZINE DERIVATIVES MERCK PATENT GMBH (DE) 1999-01-28 WO disclosed
WO-1998057953-A1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 1998-12-23 WO disclosed